Spots Global Cancer Trial Database for Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Imaging Trial With I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
Official Title: Phase 2, Open-Label, Imaging Trial of I-124-CLR1404 in Patients With Newly Diagnosed or Recurrent Glioblastoma
Study ID: NCT01898273
Conditions
Interventions
Study Description
Brief Summary: The primary objective of this trial is to determine the optimal dose and imaging time point(s) of I-124-CLR1404 in subjects with newly diagnosed and recurrent glioma to be used in future trials.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
City of Hope, Duarte, California, United States
Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
University of Maryland School of Medicine, Baltimore, Maryland, United States
Cleveland Clinic, Cleveland, Ohio, United States
Ohio State University Medical Center, Columbus, Ohio, United States
Kettering Medical Center, Kettering, Ohio, United States
Hospital of University of Pennsylvania, Philadelphia, Pennsylvania, United States
University of Wisconsin, Madison, Wisconsin, United States
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Contact Details
Name: John Kuo, MD, PhD
Affiliation: University of Wisconsin, Madison
Role: PRINCIPAL_INVESTIGATOR
Name: Jana Portnow, MD
Affiliation: City of Hope Medical Center
Role: PRINCIPAL_INVESTIGATOR
Name: Abass Alavi, MD
Affiliation: University of Pennsylvania
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
